Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Net Cash Flow (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) recorded Net Cash Flow of $5,420 in Q4 2025.

Analysis

Drugs Made In America Acquisition (DMAA) Net Cash Flow (2024 - 2026) Analysis & Trends

For FY2025, Drugs Made In America Acquisition reported Net Cash Flow of $4,786, up 254.3% from FY2024.

  • Across earlier years, Net Cash Flow came in at $1,351 in FY2024.
  • Per Business Quant, the preceding three quarters came in at -$105.00 (Q3 2025), -$101.00 (Q2 2025) and -$428.00 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 2.40 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 489.21 Mn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 1.47 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - -815.00 Mn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -5.57 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 46.41 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 45.04 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -98.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -98.71 Mn
Mar 31, 2026 8,750.00
Dec 31, 2025 5,420.00
Sep 30, 2025 -105.00
Jun 30, 2025 -101.00
Mar 31, 2025 -428.00
Dec 31, 2024 -106.00
Sep 30, 2024 2,095.00
API Access

Drugs Made In America Acquisition Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=DMAA&period=max&api_key=YOUR_API_KEY